Cargando…

In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection

BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) first emerged in the Kingdom of Saudi Arabia, is associated with a high mortality rate. AIM: To determine the effect of MERS-CoV on the immune response in infected patients and investigate cytokine production in the A549 epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Mubarak, Ayman, Alrfaei, Bahauddeen, Aljurayyan, Abdullah, Alqafil, Mahfoudh M, Farrag, Mohamed A, Hamed, Maaweya E, Alosaimi, Bandar, Almajhdi, Fahad, Alturaiki, Wael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149276/
https://www.ncbi.nlm.nih.gov/pubmed/34045884
http://dx.doi.org/10.2147/JIR.S312337
_version_ 1783697929946529792
author Mubarak, Ayman
Alrfaei, Bahauddeen
Aljurayyan, Abdullah
Alqafil, Mahfoudh M
Farrag, Mohamed A
Hamed, Maaweya E
Alosaimi, Bandar
Almajhdi, Fahad
Alturaiki, Wael
author_facet Mubarak, Ayman
Alrfaei, Bahauddeen
Aljurayyan, Abdullah
Alqafil, Mahfoudh M
Farrag, Mohamed A
Hamed, Maaweya E
Alosaimi, Bandar
Almajhdi, Fahad
Alturaiki, Wael
author_sort Mubarak, Ayman
collection PubMed
description BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) first emerged in the Kingdom of Saudi Arabia, is associated with a high mortality rate. AIM: To determine the effect of MERS-CoV on the immune response in infected patients and investigate cytokine production in the A549 epithelial cell line in response to a recombinant MERS-CoV spike protein (rSP) in the presence or absence of anti-dipeptidyl peptidase 4 (DPP4) antibody (3 independent experiments). Cytokine levels were measured using a cytokine ELISA array. METHODS: A Bio-Plex multiplex assay and cytokine ELISA were used in our study to measure the cytokine levels. RESULTS: Comparative analysis of MERS-CoV-infected patients (4 samples) and noninfected healthy controls (HCs) (5 samples) showed that serum levels of the following cytokines and chemokines were significantly higher in MERS-CoV patients than in the HCs (*p < 0.05): interferon (IFN)-α2 (43.4 vs 5.4), IFN-β (17.7 vs 6.2), IFN-γ (43.4 vs 9.7), interleukin (IL)-8 (13.7 vs 0), IL-2 (11.2 vs 3), IL-27p28 (57.8 vs 13.8), and IL-35 (167.5 vs 87.5). DISCUSSION: Our results revealed that MERS-CoV infection induced a slight increase in IFN levels but triggered a more pronounced increase in expression of the regulatory cytokines IL-27 and IL-35. A recombinant version of the full-length MERS-CoV spike protein increased the expression of IL-8 (160 pg/mL), IL-2 (100 pg/mL) and IL-12 (65 pg/mL) in A549 lung epithelial cells compared to that in the unstimulated control cells. The presence of anti-DPP4 antibody did not affect cytokine suppression or induction in A549 cells in vitro but decreased the level of IL-8 from 160 pg/mL to 65 pg/mL. CONCLUSION: MERS-CoV can decrease IFN levels to interfere with the IFN pathway and enhance the production of regulatory cytokines. Inhibition of the increases in IL-27 and IL-35 may contribute to halting MERS-CoV in the early stage of infection.
format Online
Article
Text
id pubmed-8149276
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81492762021-05-26 In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection Mubarak, Ayman Alrfaei, Bahauddeen Aljurayyan, Abdullah Alqafil, Mahfoudh M Farrag, Mohamed A Hamed, Maaweya E Alosaimi, Bandar Almajhdi, Fahad Alturaiki, Wael J Inflamm Res Original Research BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) first emerged in the Kingdom of Saudi Arabia, is associated with a high mortality rate. AIM: To determine the effect of MERS-CoV on the immune response in infected patients and investigate cytokine production in the A549 epithelial cell line in response to a recombinant MERS-CoV spike protein (rSP) in the presence or absence of anti-dipeptidyl peptidase 4 (DPP4) antibody (3 independent experiments). Cytokine levels were measured using a cytokine ELISA array. METHODS: A Bio-Plex multiplex assay and cytokine ELISA were used in our study to measure the cytokine levels. RESULTS: Comparative analysis of MERS-CoV-infected patients (4 samples) and noninfected healthy controls (HCs) (5 samples) showed that serum levels of the following cytokines and chemokines were significantly higher in MERS-CoV patients than in the HCs (*p < 0.05): interferon (IFN)-α2 (43.4 vs 5.4), IFN-β (17.7 vs 6.2), IFN-γ (43.4 vs 9.7), interleukin (IL)-8 (13.7 vs 0), IL-2 (11.2 vs 3), IL-27p28 (57.8 vs 13.8), and IL-35 (167.5 vs 87.5). DISCUSSION: Our results revealed that MERS-CoV infection induced a slight increase in IFN levels but triggered a more pronounced increase in expression of the regulatory cytokines IL-27 and IL-35. A recombinant version of the full-length MERS-CoV spike protein increased the expression of IL-8 (160 pg/mL), IL-2 (100 pg/mL) and IL-12 (65 pg/mL) in A549 lung epithelial cells compared to that in the unstimulated control cells. The presence of anti-DPP4 antibody did not affect cytokine suppression or induction in A549 cells in vitro but decreased the level of IL-8 from 160 pg/mL to 65 pg/mL. CONCLUSION: MERS-CoV can decrease IFN levels to interfere with the IFN pathway and enhance the production of regulatory cytokines. Inhibition of the increases in IL-27 and IL-35 may contribute to halting MERS-CoV in the early stage of infection. Dove 2021-05-21 /pmc/articles/PMC8149276/ /pubmed/34045884 http://dx.doi.org/10.2147/JIR.S312337 Text en © 2021 Mubarak et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mubarak, Ayman
Alrfaei, Bahauddeen
Aljurayyan, Abdullah
Alqafil, Mahfoudh M
Farrag, Mohamed A
Hamed, Maaweya E
Alosaimi, Bandar
Almajhdi, Fahad
Alturaiki, Wael
In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
title In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
title_full In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
title_fullStr In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
title_full_unstemmed In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
title_short In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection
title_sort in vivo and in vitro evaluation of cytokine expression profiles during middle east respiratory syndrome coronavirus (mers-cov) infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149276/
https://www.ncbi.nlm.nih.gov/pubmed/34045884
http://dx.doi.org/10.2147/JIR.S312337
work_keys_str_mv AT mubarakayman invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT alrfaeibahauddeen invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT aljurayyanabdullah invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT alqafilmahfoudhm invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT farragmohameda invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT hamedmaaweyae invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT alosaimibandar invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT almajhdifahad invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection
AT alturaikiwael invivoandinvitroevaluationofcytokineexpressionprofilesduringmiddleeastrespiratorysyndromecoronavirusmerscovinfection